Xoma spins off CLAS operations into newly formed Algonova Bio ahead of planned IPO

• Xoma moved its CLAS operations into newly registered subsidiary Algonova Bio, set up May 4, 2026 in Gothenburg.
• The separate structure targets standalone development and financing for Algonova Bio, while Xoma refocuses on its core FLOW water-treatment platform.
• Xoma is preparing Algonova Bio for an IPO, with a timetable expected shortly.
• Management aims to distribute Algonova Bio shares to Xoma shareholders ahead of a listing or sale.
• An independent paid analysis previously valued the CLAS business at SEK 30-40 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xoma AB published the original content used to generate this news brief via Cision (Ref. ID: 202609030830BITN____UKPR__SV_20260903-BIT-6079-0) on September 03, 2026, and is solely responsible for the information contained therein.